Parent Weigh Risks as Pfizer Vaccine for Kids under 5 Nears Authorization

Written by on February 5, 2022

Earlier this week, Pfizer and its partner BioNTech applied for authorization for a two-dose regimen at the FDA’s request, even though officials announced in December that two shots did not produce a sufficient immune response in children ages 2 to 4. However, there are trials still underway for a third dose, but data will not be available until late next month. Now the question is, how many parents will choose to vaccinate their children? According to a poll conducted by the Kaiser Family Foundation, only 26% of parents said they would not. Check the poll below:

Surgeon General Dr. Vivek Murthy stated: “We do not know yet if this vaccine is going to be safe and effective for children under 5. That’s exactly why the FDA is beginning a process of rigorous review and that’s going to be a transparent process.”

Source: 13 WHAM


[There are no radio stations in the database]